RenovoRx, Inc.
RenovoRx, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for the treatment of solid tumors. Its lead product candidate is RenovoGem, a drug and device combination consisting of intra-arterial gemcitabine and RenovoCath …
Biotechnology
US, Los Altos [HQ]
Strategy & Leadership
Mergers & Acquisitions Beta
M&As
M&A Deals · Breakdown
RenovoRx, Inc. has no acquisition track records yet.
M&A Deals · History
RenovoRx, Inc. has no acquisition track records yet.